ICAM1 and diabetic kidney disease: In patients with known diabetic kidney disease low-grade inflammation, calculated based on C-reactive protein, interleukin-6, soluble intercellular adhesion molecule-1, and secreted phospholipase A2, was shown to be associated with an increased risk of all-cause mortality after 10 years of follow-up (78).